6/2/2023  9:59:55 PM Chg. +1.37 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
104.20USD +1.33% 108,435
Turnover: 11.25 mill.
-Bid Size: - -Ask Size: - 181.2 bill.USD 1.84% 26.45

Business description

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 160 countries.

Management board & Supervisory board

Robert B. Ford
Management board
Robert E. Funck, Jr., Alejandro Wellisch, Andrea F. Wainer, Andrew H. Lane, Christopher J. Calamari, Daniel Salvadori, Dr. John M. Capek, Greg Ahlberg, Hubert L. Allen, J. Scott House, Jared L. Watkin, John F. Ginascol, Joseph Manning, Julie Tyler, Lisa D. Earnhardt, Louis H. Morrone, Mary K. Moreland, Michael Dale, Michael J. Pederson, Randel Woodgrift, Sammy G. Karam
Supervisory board
Robert B. Ford, Daniel J. Starks, Darren W. McDew, Dr. Sally E. Blount, Glenn F. Tilton, John G. Stratton, Michael F. Roman, Michelle A. Kumbier, Nancy McKinstry, Patricia P. Gonzalez, Robert J. Alpern, Roxanne S. Austin, William A. Osborn

Company data

Name: Abbott Laboratories
Address: 100 Abbott Park Road,Abbott Park Illinois, Chicago 60064-3500, USA
Phone: +1-224-667-6100
Fax: -
E-mail: -
Internet: www.abbott.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 87.10%
IPO date: -

Investor relations

Name: Scott Leinenweber
IR phone: +1-224-667-8945
IR Fax: -
IR e-mail: -

Main Shareholders

The Vanguard Group
BlackRock, Inc.